Patients with asymptomatic allergic conjunctivitis
Conditions
Interventions
Subjects will be randomly assigned to 2 groups, the observation period will be 3 weeks, and the antigen-induced drug efficacy will be evaluated by crossover between the standard formulation group and
Sponsors
Atsuki Fukushima
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1 At the time of obtaining consent 1)Persons aged between 20 and 50 who can obtain written consent 2)Gender :Male /Female 3) Persons with subjective symptoms and objective findings associated with allergic conjunctivitis in the past 2 Until the visit 2 end 4)No symptoms or findings of pruritus and conjunctival hyperemia in both eyes before antigen induction 5)Those with an eye itching sensation and conjunctival hyperemia grade 2 or higher due to antigen induction in both eyes.
Exclusion criteria
Exclusion criteria: 1 At the time of obtaining consent 1)Inflammatory eye disease (vernal conjunctivitis,atopic conjunctivitis, blepharitis etc. ) complications of the external or anterior segment of the eye 2)Contact lens wearers 3)Oher patients who have been considered inappropriate as clinical trial subjects by investigator or sub- investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| itchiness of the eye, slit lamp microscopy, image analysis of bulbar conjunctival hyperemia, NIBUT | — |
Secondary
| Measure | Time frame |
|---|---|
| Eye surface temperature measurement, Eye surface blood flow eye surface temperature measurement and eye surface blood flow measurement, Body temperature measurement, blood pressure measurement | — |
Contacts
Public ContactFukushima Atsuki
Samoncho Clinic
Outcome results
None listed